Skip to main content
OpenTrials
Completed

NCT Number: NCT01626235

AMPED Outcomes Registry of Post-ED Pain Management

Study aims to assess patient-recorded outcomes of pain control medications prescribed in the ER after visits for specific painful injuries/illnesses.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Multicenter, observational, prospective, out-of-hospital registry collecting clinical, satisfaction, quality of life, and healthcare resource utilization from subjects discharged after ED care for a specific acute pain syndrome with a clinician-determined analgesic regimen. Subjects are stratified by diagnosis and by regimen based on the treating clinician's judgment. The registry study is independent of ED care and clinician's decision-making.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible subjects will meet the following criteria:
  • Eligible diagnoses:

musculoskeletal etiologies: acute extremity fractures sprains/strains acute gouty arthritis visceral etiologies: renal colic dysmenorrhea

  • Age GTE 18 years;
  • Decision to discharge from ED to community already made;
  • Decision to give SPRIX, opioid, OR SPRIX + opioid rescue already made;
  • Treating clinician deems patient appropriate for continued analgesic management as an outpatient for the next 3-5 days;
  • Patient has ready touch-tone (mobile or land line) telephone access, provides number (and back-up number, if possible) and agrees (verbal or written consent as mandated by site) to answer and comply with brief IVR questionnaires daily for next 4 days.

Exclusion criteria

  • Eligible subjects will meet none of the following criteria:
  • Patient admitted or placed on observation status from ED;
  • Patient unwilling or unable to comply with telephonic follow-up;
  • Fracture that requires surgical repair (even if at a later date);
  • Patient has diagnosis of any chronic pain syndrome;
  • Patient already routinely takes NSAID or opioid agent;
  • Treating clinician has reasonable suspicion of drug-seeking behavior or noncompliance;
  • Nasal abnormality or illness that could affect the absorption of intranasal medication (such as: nasal discharge, rhinitis, acute upper respiratory infection, acute epistaxis, nasal polyp, nasal tumor).

Treatment and study plan

Primary outcomes

  1. Clinical Outcomes of pain control measures

    Time frame: 5 days

    • Change in pain score over follow-up interval;
    • Healthcare resource utilization during follow-up interval;
    • Patient satisfaction with therapy;
    • Return to work in employed cohort.

Secondary outcomes

  1. Satisfaction and Economic Outcomes

    Time frame: 5 days

    • Effectiveness of work upon return;
    • Relative adverse effect profiles of three treatment regimens;
    • Compliance with therapy;
    • QOL at conclusion of therapy.

Sponsors and collaborators

Lead sponsor

Radnor Registry Research, Inc

Industry

Collaborators

  • American Regent, Inc.

Registry information

Official study title

Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain

Acronym: AMPED

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Jun 22, 2012
Registry last updated
Mar 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.